Rare Neurodegenerative Diseases Market Will Witness Steady Growth Through 2030, Use of Plant Polyphenols to Gain Traction; Fact.MR
The global rare neurodegenerative disease treatment market is projected to surpass a valuation of US$ 116 billion by 2030, according to a new study by Fact.MR. Medical technology advancements offer consistent and better results, thereby, acting as a priority in the healthcare sector. This has projected as a major growth aspect for the market.
View full press release